Superoxide dismutase (SOD) vs placebo
Retinopathy of prematurity · preterm infants at risk for bronchopulmonary dysplasia
It is very uncertain whether superoxide dismutase (SOD) changes retinopathy of prematurity№ of participants: 277(2 RCTs) compared with placebo (very low certainty).
1 finding from 1 review
- Superoxide dismutase for bronchopulmonary dysplasia in preterm infants 2023 · Cochrane Headline outcomes onlyRR 0.95 [0.78, 1.15]Studies not reportedVery low